These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 15551657)

  • 1. Simvastatin induces death of multiple myeloma cell lines.
    Gronich N; Drucker L; Shapiro H; Radnay J; Yarkoni S; Lishner M
    J Investig Med; 2004 Jul; 52(5):335-44. PubMed ID: 15551657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-administration of simvastatin and cytotoxic drugs is advantageous in myeloma cell lines.
    Drucker L; Afensiev F; Radnay J; Shapira H; Lishner M
    Anticancer Drugs; 2004 Jan; 15(1):79-84. PubMed ID: 15090747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microenvironment factors do not afford myeloma cell lines protection from simvastatin.
    Osadchy A; Drucker L; Radnay J; Shapira H; Lishner M
    Eur J Haematol; 2004 Sep; 73(3):183-90. PubMed ID: 15287916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antimyeloma effects of zoledronate and simvastatin.
    Schmidmaier R; Simsek M; Baumann P; Emmerich B; Meinhardt G
    Anticancer Drugs; 2006 Jul; 17(6):621-9. PubMed ID: 16917207
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Terzi H; Altun A; Şencan M
    Indian J Med Res; 2019 Dec; 150(6):630-634. PubMed ID: 32048627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma.
    van der Spek E; Bloem AC; Lokhorst HM; van Kessel B; Bogers-Boer L; van de Donk NW
    Leuk Res; 2009 Jan; 33(1):100-8. PubMed ID: 18621417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
    Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
    Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serenoa repens induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of STAT 3 signaling.
    Che Y; Hou S; Kang Z; Lin Q
    Oncol Rep; 2009 Aug; 22(2):377-83. PubMed ID: 19578780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in multiple myeloma cells by a statin-thalidomide combination can be enhanced by p38 MAPK inhibition.
    Slawinska-Brych A; Zdzisinska B; Mizerska-Dudka M; Kandefer-Szerszen M
    Leuk Res; 2013 May; 37(5):586-94. PubMed ID: 23434428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells.
    Huang H; Wu D; Fu J; Chen G; Chang W; Chow HC; Leung AY; Liang R
    Eur J Haematol; 2009 Sep; 83(3):191-202. PubMed ID: 19467017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells.
    Saito A; Saito N; Mol W; Furukawa H; Tsutsumida A; Oyama A; Sekido M; Sasaki S; Yamamoto Y
    Melanoma Res; 2008 Apr; 18(2):85-94. PubMed ID: 18337644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calmodulin antagonists induce cell cycle arrest and apoptosis in vitro and inhibit tumor growth in vivo in human multiple myeloma.
    Yokokura S; Yurimoto S; Matsuoka A; Imataki O; Dobashi H; Bandoh S; Matsunaga T
    BMC Cancer; 2014 Nov; 14():882. PubMed ID: 25424011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
    McMillin DW; Ooi M; Delmore J; Negri J; Hayden P; Mitsiades N; Jakubikova J; Maira SM; Garcia-Echeverria C; Schlossman R; Munshi NC; Richardson PG; Anderson KC; Mitsiades CS
    Cancer Res; 2009 Jul; 69(14):5835-42. PubMed ID: 19584292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BSc2118 is a novel proteasome inhibitor with activity against multiple myeloma.
    Sterz J; Jakob C; Kuckelkorn U; Heider U; Mieth M; Kleeberg L; Kaiser M; Kloetzel PM; Sezer O; von Metzler I
    Eur J Haematol; 2010 Aug; 85(2):99-107. PubMed ID: 20374272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin inhibits proliferation and induces apoptosis of multiple myeloma cells through regulation of Bcl-2 and Bax and suppression of VEGF.
    Ding JH; Yuan LY; Huang RB; Chen GA
    Eur J Haematol; 2014 Oct; 93(4):329-39. PubMed ID: 24766194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
    Romagnoli M; Desplanques G; Maïga S; Legouill S; Dreano M; Bataille R; Barillé-Nion S
    Clin Cancer Res; 2007 Oct; 13(20):6010-8. PubMed ID: 17947462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mevalonate/isoprenoid pathway inhibitor apomine (SR-45023A) is antiproliferative and induces apoptosis similar to farnesol.
    Flach J; Antoni I; Villemin P; Bentzen CL; Niesor EJ
    Biochem Biophys Res Commun; 2000 Apr; 270(1):240-6. PubMed ID: 10733934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decursin chemosensitizes human multiple myeloma cells through inhibition of STAT3 signaling pathway.
    Kim HJ; Kim SM; Park KR; Jang HJ; Na YS; Ahn KS; Kim SH; Ahn KS
    Cancer Lett; 2011 Feb; 301(1):29-37. PubMed ID: 21122982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of (S)-HDAC42, a phenylbutyrate-derived histone deacetylase inhibitor, in multiple myeloma cells.
    Bai LY; Omar HA; Chiu CF; Chi ZP; Hu JL; Weng JR
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):489-96. PubMed ID: 21072520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of thalidomide by human liver microsome cytochrome CYP2C19 is required for its antimyeloma and antiangiogenic activities in vitro.
    Li Y; Jiang Z; Xiao Y; Li L; Gao Y
    Hematol Oncol; 2012 Mar; 30(1):13-21. PubMed ID: 21638302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.